We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.00 | 17.50 | 18.50 | 18.00 | 18.00 | 18.00 | 66,018 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.34 | 16.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/8/2018 16:33 | Just for you ray UKOG The stupidity of UK Oil & Gas owning David Lenigas sycophants on twitter - meet Donato Perretta | slartybartfaster | |
22/8/2018 16:07 | Afraid so. Some inside jobs here! | rayrac | |
22/8/2018 15:57 | Rampers still crying? | monkeywench1 | |
22/8/2018 15:57 | Let's hope so ... continual red for last 2 weeks is not so good | suzypink | |
22/8/2018 15:16 | Buying opp on low volumes as holiday season comes to an end, between now and Xmas is going to be manic for OPTI!;0) | trotterstrading | |
22/8/2018 14:24 | Yes Ray, i was thinking that too. The difference, so many have learned so much, you have not course. lol | slartybartfaster | |
22/8/2018 13:56 | I'm surprised there are so many ex bioprogress guys here. Once is enough surely! | rayrac | |
22/8/2018 13:35 | Still wasting time talking about the skidmark that is Rayrac. It's been days now. Would you like me to show you all where the filter button is? Let's shrink the tumour by not feeding it, please folks. He is loving this attention. | polus | |
22/8/2018 13:22 | My first order of Lactobact® LDL-CONTROL from Apo-Rot online pharmacy was 6/8/17 and my test was in November aprox 3 months later. How my results have any thing to do with how much I post is beyond me but then rayrac isnt the sharpest tool in the box. | badger777 | |
22/8/2018 13:04 | trust me not to check before posting | humphries1 | |
22/8/2018 13:00 | Humph - there's two 'f's in off :) | m4rtinu | |
22/8/2018 12:56 | oh i now see why his brain is so twisted | humphries1 | |
22/8/2018 12:48 | Oh he has Loads of good words for UKOG That’s struggling to get over 2p a share Less than a year ago it was 5 times that price! :) | judijudi | |
22/8/2018 12:32 | rayrac has festered many boards and has never said owt good about any company | humphries1 | |
22/8/2018 12:27 | Rayrac...you appear to spend a good proportion of your day here? Why??? Clearly you do not hold the shares.... Are you short? Just wondering. Don't buy that you are here to protect gullible investors one little bit... Have seen you over years via bio progress (bitter losses me too) and antisoma and several others. You seem to get more bitter and twisted with age. Why don't you bring some proper research to the table if are so adamant this is going nowhere... Suspect cos you can't??? Anyway said my piece I am happy where this is heading and very happy with my shareholding. | meganxmas | |
22/8/2018 12:17 | f@@k of rayrac | humphries1 | |
22/8/2018 11:40 | You are a highly experienced poster..not. Badger. 9 posts in 9mths since Nov 2017, yet your self tests go back further! Something suspicious there. | rayrac | |
22/8/2018 11:28 | Thesse are my last results which the doctor said were a very good improvement. Total Cholesterol stayed the same but the bad cholesterol went down and the good went up. Diet and excercise stayed the same BEFORE taking LDL Control Se non HDL cholesterol level 3.4 mmol/L 0 - 2.8 Abnormal 18 Jul 2016 After Se non HDL cholesterol level 2.9 mmol/L 0 - 3.9 Normal 6 Nov 2017 Before Serum cholesterol/HDL ratio 3.6 After Serum cholesterol/HDL ratio 2.6 Before Serum HDL cholesterol level 1.3 mmol/L 1.0 - 9999 Normal 18 Jul 2016 After Serum HDL cholesterol level 1.8 mmol/L 1.0 - 3.0 Normal 6 Nov 2017 Before Serum total cholesterol level 4.7 mmol/L After Serum total cholesterol level 4.7 mmol/L | badger777 | |
22/8/2018 10:51 | Soh should have been on Donald Trump’s campaign! So 12 weeks trials leads to a product that has control of glucose, control of bp, control of cholesterol levels and the reduction of cardiovascular risk?! Yes, and I was born yesterday. | rayrac | |
22/8/2018 09:21 | Fine Foods is based in Italy and has more than 30 years' experience in the design, development and manufacture of customised formulations and presentations for the pharmaceutical and food supplement industry. With revenues of EUR120m in 2017, it is one of Europe's largest and fastest growing providers of food supplements and pharmaceutical products, with full GMP certified production facilities and leading pharmaceutical companies such as Pfizer, Bayer, Sanofi etc reported as customers on its website.It is also misses that it's not just one product or revenue stream from each partner in many cases it is multiple:Fine Foods has an international reputation and world leading expertise in developing unique formulations and presentations containing probiotic strains. Under the terms of the agreement, Fine Foods have an exclusive license to produce and commercialise five new formulations containing OptiBiotix's LP(LDL) (R) . One for glucose control, one for reduction of high blood pressure, one for reduction of cholesterol levels and two for the reduction of cardiovascular risk. | riskybusiness1 | |
22/8/2018 09:16 | Go Figure was launched with hardly any marketing budget and turns over £100k purely on word of mouth. The B2B strategy which is the primary route for Optis commercialisation includes companies that are well established and fast growing in their respective sectors. Before signing these deals they will go out and see if their is demand for such a product within their existing customer base.Giorgio Ferraris, CEO of Fine Foods, commented: "We are very excited to enter this agreement with OptiBiotix, which will allow us to promote specific formulations and presentations containing the innovative OptiBiotix's LP(LDL) (R) strain to customers active in the growing market segment of Cholesterol and Blood pressure reduction, as well as Cardiovascular risk. We believe this a unique opportunity for us to expand our commercial presence in the European Food Supplement industry, and has the potential to favourably enhance our existing rate of growth over the coming years."Just to repeat: "We believe this a unique opportunity for us to expand our commercial presence in the European Food Supplement industry, and has the potential to favourably enhance our existing rate of growth over the coming years." I'd say it would be a reasonable assumption to say these products are going to sell considering the views from those that would be selling them. | riskybusiness1 | |
22/8/2018 09:16 | New customer in France.More products to launch in US in Nov at SSW (late stage negotiations will soon turn into deals).Interims on the 30th Aug.Online store launch 3rd Sept.Pharma interest building. Global interest in LP-LDL building.Potentially spinning out probiotic division in near future. Plus lots more! | parob | |
22/8/2018 08:40 | Revenues building - Per Rehne interview just out proactiveinvestors.c | woodaldo | |
22/8/2018 08:38 | You are making a large assumption that the end user I.e the consumer will buy the product in large quantities. Go figure didn't exactly set the world alight. | monkeywench1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions